Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidicity

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 4, 1998, Pages 337-342

  Netzer, P ^a   Brabetz Hofliger A ^a   Brundler R ^a   Flogerzi, B ^a   Husler J ^a   Halter, F ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; NON PRESCRIPTION DRUG; PLACEBO; RANITIDINE; RENNIE;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DYSPEPSIA; HEADACHE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ACID SECRETION; STOMACH PH; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; ANTACIDS; CALCIUM CARBONATE; CARBONATES; DOUBLE-BLIND METHOD; DYSPEPSIA; FAMOTIDINE; FEMALE; GASTRIC ACID; HISTAMINE H2 ANTAGONISTS; HUMANS; MAGNESIUM; MALE; PAIN; RANITIDINE; TIME FACTORS;

EID: 0031897518     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00316.x     Document Type: Article

References (21)

1. Drossmann DA, Li Z, Andruzzi K. et al. U.S. householder survey of functional gastrointestinal disorders - prevalence. sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-80.
2. Oster G, Huse DM, Delea TE, Colditz GA, Richter JM. The risk and benefits of an Rx-to-OTC switch. Med Care 1990; 28: 834-52.
3. 2 receptor antagonists safe over the counter drugs? Br Med J 1994; 309: 493-4.
4. 2-receptor antagonists. Arch Intern Med 1993; 153: 2415-24.
5. 2-receptor antagonist (famotidine). Am J Ther 1995; 2: 304-13.
6. Feldman M. Comparison of the effects of over-the-counter famotidine and calcium carbonate antacid on postprandial gastric acid. J Am Med Assoc 1996; 275: 1428-31.
7. Blackwell JN, Wu CS, Castell DO. Clinical applications of oesophageal mutility studies? Br J Hosp Med 1984; 32: 267-71.
8. Ducrotte P, Weber J, Colin R, Denis P. Effect of an effervescent citrale-cimetidine combination on intragastric pH in healthy subjects. Gastroenterol Clin Biol 1992; 16: 162-5.
9. Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987; 28: 1120-7.
10. 2-antagonists. Gastroenterology 1985; 88: 1842-51.
11. Netzer P, Hammer B. Indikationen. Resultate und Konsequenzen der 24 Stunden-Oesophagus-pH-Metrie hei 50 konsekutiven Patienten. Schweiz Med Wochenschr 1996; 126: 55-7.
12. Hürlimann S, Abbühl B, Inauen W, Halter F. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole. Aliment Pharmacol Ther 1994; 8: 193-201.
13. Wilder-Smith CH, Gennoni MA, Triller J, Scheurer U, Merki HS. Is a fluoroscopic verification of the electrode position necessary in ambulatory intragastric pH monitoring. Digestion 1992; 52: 1-5.
14. Hüsler J, Zimmermann H. Statistische Prinzipien für medizinische Projekte, 2nd edn. Bern: Hans Huber, 1996.
15. Labenz J, Peitz C, Leusing C, Tillenburg B, Blum AL, Börsch G. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study. Gut 1997; 40: 36-41.
16. Mann SG, Murakami A, McCarroll K, Rao AN, Cottrell J, Mehentee J. Low dose famotidine in prevention of sleep disturbance caused by heartburn after an evening meal. Aliment Pharmacol Ther 1995; 9: 395-401.
17. Reilly TG, Mann SG, Panos MZ, Walt RP. Low dose famotidine and cimetidine in single postprandial doses: a placebo controlled comparative study of overnight pH. Gut 1995; 37: 525-8.
18. Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205-8.
19. 2-receptor antagonists in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1995; 9(Suppl. 1): 9-14.
20. Netzer P, Gaia C, Huluk T. et al. Effect of repeated bolus injection vs. continuous infusion of high dose omeprazole and ranitidine on intragastric pH for 72 hours. Gastroenterology 1997; 112: A233(Abstract).
21. 2-receptor antagonists. Aliment Pharmacol Ther 1990; 4(Suppl. 1p): 15-17.